RNU7-103P

Across TCGA pan-cancer cohorts, RNU7-103P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU7-103P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU7-103P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-103P expression acts as an unfavorable survival marker, although some lineages such as HNSC and LAML show a favorable association.

ESCA, KIRC, and PAAD are the cancer types where RNU7-103P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	II,III,IV	0.273	0.559	<.001	84	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	72	view →
PAAD	OS	Tertile	All	0.289	0.619	.004	54	view →
HNSC	DFS	Tertile	All	0.780	0.506	.017	42	view →
SARC	DFS	Tertile	All	0.086	0.591	.001	18	view →
CESC	OS	Tertile	All	0.611	0.880	.007	18	view →
LGG	DFS	Tertile	All	0.268	0.753	.029	9	view →
BRCA	OS	Tertile	II,III,IV	0.355	0.571	.032	6	view →
LAML	DFS	Median	All	0.530	0.385	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU7-103P–ESCA (OS)

Open the ESCA breakdown →